GHK-Cu
2 RCTsWell researched
| Improves skin appearance (topical) | supported |
| Stimulates collagen | partially true |
| Injected equals topical benefit | weak evidence |
Goal matrix
Every compound we track for this goal.
| Improves skin appearance (topical) | supported |
| Stimulates collagen | partially true |
| Injected equals topical benefit | weak evidence |
| Approved as afamelanotide for erythropoietic protoporphyria | supported |
| Increases tanning with less UV exposure | partially true |
| Safe for unsupervised cosmetic use | overreach |
| Produces skin darkening through melanocortin-1 receptor activation | partially true |
| It is the same compound as the approved melanotan sold as Scenesse | overreach |
| Tanning with it protects the skin against sun damage | overreach |
| Has been associated in case reports with changes in existing moles and with new melanocytic lesions | supported |
All content on Peptuity is provided for research and educational purposes only. Peptuity does not sell, distribute, or facilitate the purchase of any compound, does not provide medical advice, and makes no claims regarding safety or efficacy. Most compounds discussed are not approved for human use by the SFDA or FDA. Always consult a qualified physician.